Skip to main content
Equibles

MORGAN STANLEY

Position in PRQR — ProQR Therapeutics N.V.

CIK 895421 NEW YORK, NY
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,287,019
+$1,181,384 QoQ
Shares Held
1,767,215
+36.0% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 69 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. PRQR ranks #185 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in PRQR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,287,019 1,767,215
2026-03-31 $2,105,635 1,299,775
2025-12-31 $2,761,579 1,367,119
2025-09-30 $6,179,558 2,901,202
2025-06-30 $6,290,318 3,083,490
2025-03-31 $1,840,044 1,383,493
2024-12-31 $1,287,859 485,985
2024-09-30 $499,498 274,450
2024-06-30 $129,383 77,942
2024-03-31 $154,783 67,591
2023-12-31 $225,146 113,711
2023-09-30 $445,845 342,958
2023-06-30 $802,735 495,516
2023-03-31 $1,382,067 648,858
2022-12-31 $1,401,004 378,650
2022-09-30 $355,416 477,713
2022-06-30 $310,261 398,795
2022-03-31 $182,721 201,904
2021-12-31 $293,333 36,621
2021-09-30 $929,654 111,070
2021-06-30 $2,594,035 384,872
2021-03-31 $3,176,520 480,563
2020-12-31 $4,259,114 1,014,075
2020-09-30 $1,030,370 215,109
2020-06-30 $2,370,458 389,878
2020-03-31 $1,117,115 203,482